| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $4.39B | +7.1% |
| Cost of Revenue | $1.10B | +4.4% |
| Gross Profit | $3.29B | +8.1% |
| R&D Expense | $774.1M | +113.2% |
| SG&A Expense | $576.4M | +19.4% |
| Operating Income | $245.4M | -76.9% |
| Pre-tax Income | $249.3M | -77.4% |
| Income Tax | $145.6M | +153.1% |
| Net Income | $103.7M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.09B | +2.3% |
| Accounts Receivable | $557.4M | +32.8% |
| Current Assets | $6.36B | +2.8% |
| Total Assets | $8.13B | +7.6% |
| Current Liabilities | $1.74B | +10.1% |
| Total Liabilities | $1.92B | +8.5% |
| Stockholders' Equity | $6.21B | +7.4% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.29B | -19.6% |
| Capital Expenditures | $103.8M | -21.7% |
| Investing Cash Flow | -$318.3M | +88.9% |
| Financing Cash Flow | -$936.9M | -2850.2% |
| Free Cash Flow | $1.19B | -19.4% |
| -92.5% |
| EPS (Basic) | $0.35 | -92.5% |
| EPS (Diluted) | $0.34 | -92.4% |